alexa Obesity- The Big Problem | 14849
ISSN: 2165-7904

Journal of Obesity & Weight Loss Therapy
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference and Exhibition on Obesity & Weight Management

Bhanu K. Patibandla
Accepted Abstracts: J Obes Weight Loss Ther
DOI: 10.4172/2165-7904.S1.012
Abstract
Obesity is from the Latin obesitas, which means "stout, fat, or plump". Medically, obesity is known as a condition in which excess body fat has accumulated to the extent that it may have an adverse effect on health, leading to reduced life expectancy and/or increased health problems. People are considered obese when the body mass index (BMI) exceeds 30 kg/m 2 . It has become a global epidemic affecting approximately 1.5 billion adults, and costing 150 billion dollars of health economy. It is a more common and rapidly growing problem in the United States of America (USA); the average weight of an adult worldwide is 62 kg while in the USA it is 80 kg. Though increased calorie intake, and sedentary life style has been majorly attributed to explain most cases of obesity, the other factors that should be considered in the differential include endocrine disorders, psychiatric illness, medications, genetics, and infectious agents. The United States Preventive Services Task Force recommends screening for all adults followed by behavioral interventions (Grade B recommendation) in those who are obese. It is considered important to intervene because obesity is one of the leading preventable causes of death worldwide. On average, obesity reduces life expectancy by six to seven years, a BMI of 30?35 kg/m 2 reduces life expectancy by two to four years, while severe obesity (BMI > 40 kg/m 2 ) reduces life expectancy by ten years. Public health efforts seek to understand and correct the environmental factors responsible for the increasing prevalence of obesity in the population. The main treatment for obesity consists of dieting and physical exercise. Ideal initial plan should be to lose 5-10% of body weight (1-2 lb per week) using combination of diet, physical activity, and behavioral techniques which include but not limited to self control, weight tracking, stimulus control, and group support. In case of failure to lose weight with following the above plan for at least six months, medical management is indicated for BMI>30 kg/m 2 or 27 kg/m 2 plus comorbidities. Drugs FDA approved for weight loss are Orlistat (Xenical), Locaserine (Belviq) and a combination of Phentermine and topiramate (Qsymia); Sibutramine is recently withdrawn due to cardiovascular side effects. The most effective treatment for obesity is bariatric surgery. However, due to its cost and the risk of complications, it is currently indicated for the patients with BMI >40 kg/m 2 or 35 kg/m 2 plus comorbidities. In summary, obesity management includes early intervention with dietary restrictions, and regular exercise; medical and surgical interventions with long term follow up are appropriate in certain BMI cohorts and/or when the prior management plan fails.
Biography
Bhanu K. Patibandla has obtained MBBS from Dr. NTR University of Health Sciences, India in 2010. The evidence based clinical practice and the scope for the research opportunities in the United States attracted him to pursue his further career in the USA. He worked as a post doctoral research fellow (2/2011 to 2/2012) at Beth Israel Deaconess Medical Center and Harvard Medical School, Boston in the division of nephrology. His primary areas of interest include identifying the various disparities involved in the provision of health care. He has published in the field of dialysis access, renal transplantation, and effects of BMI and comorbidities on access to renal transplantation in the diabetics. Currently, he is doing internal medicine residency training at St. Vincent Hospital, Worcester, MA.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7